Detalhe da pesquisa
1.
The plasmablast response to SARS-CoV-2 mRNA vaccination is dominated by non-neutralizing antibodies and targets both the NTD and the RBD.
medRxiv
; 2021 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33758878